This course has expired. You can still review the content but course credit is no longer available.
This continuing medical education (CME) activity captures content from a live symposium held in October of 2016 in Chicago, Illinois.
This certified CME activity is designed for ophthalmologists involved in the comanagement of postoperative cataract patients.
A CME activity provided by Evolve Medical Education LLC and distributed with Advanced Ocular Care and Cataract & Refractive Surgery Today.
Supported through an educational grant by Sun Pharmaceutical Industries Ltd.
Upon completion of this activity, the participant should be able to:
Evolve Medical Education LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA CREDIT DESIGNATION STATEMENT
Evolve Medical Education LLC designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
To obtain AMA PRA Category 1 Credit™ for this activity, you must read the activity in its entirety and complete the Post Test/ Activity Evaluation Form, which consists of a series of multiple choice questions. To answer these questions online and receive real-time results, please visit evolvemeded.com and click “Online Courses.” Upon completing the activity and achieving a passing score of over 70% on the self-assessment test, you may print out a CME credit letter awarding 1 AMA PRA Category 1 Credit™. Alternatively, please complete the Post Test/Activity Evaluation Form and mail or fax to Evolve Medical Education LLC; PO Box 358; Pine Brook, NJ 07058; Fax: (610) 771-4443. The estimated time to complete this activity is 1 hour.
It is the policy of Evolve Medical Education LLC that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve Medical Education LLC has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity.
The following faculty members have the following financial relationships with commercial interests:
John Sheppard, MD, MMSc, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: 1-800-Doctors; AbbieVie; Alcon; Aldeyra; Allergan; ArcScan; Bausch + Lomb; Bio-Tissue; Clearside; Clearview; Eleven/Lexitas; EyeGate Research; Hovione; Imprimis Pharma; Inspire/Merck Pharmaceuticals; Isis Pharmaceuticals; Kala Pharmaceuticals; Lacrisciences; Lenstatin; LayerBio; Lumenis; Lux Biosciences; NiCox; NovaBay; Novartis/CibaVision; OcuCure; Oculeve; Ocular Therapeutics; Omeros; Pentavision; Pfizer; Portage; Rapid Pathogen Screening; Santen Pharmaceuticals; Science Based Health; Shire/SarCode Biosciences; Sjo/Nicox; Stemnion; Sun Pharmaceuticals; Synedegen; Talia Technology; TearLab; TearScience; Topivert; and Vistakon. Contracted Research: Alcon; Aldeyra; Allergan; ArcScan; Bausch + Lomb; Clearview; EyeGate Research; EyeRx Research; InSite Vision; Inspire/Merck Pharmaceuticals; Isis Pharmaceuticals; Kala Pharmaceuticals; Lux Biosciences; Oculeve; Ocular Therapeutics; Pfizer; Rapid Pathogen Screening; Rutech; Santen Pharmaceuticals; Senju; Shire/SarCode Biosciences; TearScience; Vistakon; and Xoma/Servier. Stock/Shareholder: 1-800-Doctors; Alphaeon; BioLayer; Clearside; EyeGate Research; EyeRx Research; Lacrisciences; Lumenis; NovaBay; Occuhub; OcuCare; Rapid Pathogen Screening; Shire/SarCode Biosciences; Stemnion; Strathspey Crowne; and TearLab.
Johnny Gayton, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Abbott Medical Optics; Bausch + Lomb; Omerus; ScienceBased Health; Shire; and Sun Pharmaceutical Industries Ltd.
John Wittpenn, MD, has had no financial agreements or affiliations during the past year.
EDITORIAL SUPPORT DISCLOSURES
Cheryl Cavanaugh, MS, director of operations, Evolve Medical Education LLC; and Michelle Dalton, medical writer, have no financial relationships with commercial interests.
Rishi Singh, MD, peer reviewer, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Alcon; Genentech; Regeneron Pharmaceuticals; and ThromboGenics NV. Grant/Research Support: Alcon; Genentech; and Regeneron Pharmaceuticals.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve Medical Education LLC, Advanced Ocular Care, Cataract & Refractive Surgery Today, or Sun Pharmaceutical Industries Ltd.